<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药智网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-13T11:26:55+08:00</updated>
  <subtitle>一个有态度、有深度、有温度的医药健康领域融媒体平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【药咖君】东阳光1类丙肝新药即将获批！恒瑞眼科新药报产，多款重磅单抗国内上市，复宏汉霖、辉瑞…</title>
    <updated>2020-12-13T10:36:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/I8fDnlhE3bdUaiQfHtWBUg</id>
    <link href="https://mp.weixin.qq.com/s/I8fDnlhE3bdUaiQfHtWBUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>他42岁辞官从商，放弃美国绿卡，创心脑血管龙头药企！</title>
    <updated>2020-12-13T10:36:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/Mm-U6LJryT0p9TDlQiJh_Q</id>
    <link href="https://mp.weixin.qq.com/s/Mm-U6LJryT0p9TDlQiJh_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年全球畅销药品TOP10，阿达木单抗“一雪前耻”，实现正向增长！</title>
    <updated>2020-12-11T17:12:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/SSDbfcx24mDMmV3Ryeqs3A</id>
    <link href="https://mp.weixin.qq.com/s/SSDbfcx24mDMmV3Ryeqs3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点 | FDA 批准 19个 BLA 申请，多款重磅靶向药物获批上市！</title>
    <updated>2020-12-11T17:02:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/TuDjS8cec9eI28lIkxvoBg</id>
    <link href="https://mp.weixin.qq.com/s/TuDjS8cec9eI28lIkxvoBg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【好药记】5款超10亿重磅注射剂扎堆过评！扬子江占3席；豪森、全星制药...</title>
    <updated>2020-12-11T17:02:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/HNxnoyuMlbJNE9rKn_DttQ</id>
    <link href="https://mp.weixin.qq.com/s/HNxnoyuMlbJNE9rKn_DttQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美国FDA专家小组：17比4赞成紧急使用辉瑞BioNTech新冠疫苗</title>
    <updated>2020-12-11T17:02:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/bUXHXvxLMXFNpLyC04S2qQ</id>
    <link href="https://mp.weixin.qq.com/s/bUXHXvxLMXFNpLyC04S2qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家医保局会议6大要点！省级带量采购两大重磅消息传出</title>
    <updated>2020-12-11T17:02:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/jjx5Y_HTNJaEJ0oyo5ysWg</id>
    <link href="https://mp.weixin.qq.com/s/jjx5Y_HTNJaEJ0oyo5ysWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一字之差，临床研究「监查」和「稽查」有何不同？</title>
    <updated>2020-12-10T16:58:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/cug7s-vjo6N5ujhnbhRiPw</id>
    <link href="https://mp.weixin.qq.com/s/cug7s-vjo6N5ujhnbhRiPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>院士领衔，专家齐聚，Bio S&amp;T生物医药峰会开幕大会议程发布</title>
    <updated>2020-12-10T16:58:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/NuWIuJOAEcVvX6nGQ2Yr7Q</id>
    <link href="https://mp.weixin.qq.com/s/NuWIuJOAEcVvX6nGQ2Yr7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罕见病用药纳入医保？国家医保局回应：符合条件的基本已全部纳入医保</title>
    <updated>2020-12-10T16:58:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/yucddtEKMNZeqyuQBtWpVw</id>
    <link href="https://mp.weixin.qq.com/s/yucddtEKMNZeqyuQBtWpVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和铂医药上市破发，背后原因为何？</title>
    <updated>2020-12-10T16:58:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/gDSnEatwsQq0ehVhRjMTZg</id>
    <link href="https://mp.weixin.qq.com/s/gDSnEatwsQq0ehVhRjMTZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>在这里中医药占据了世界医学统治地位</title>
    <updated>2020-12-09T16:14:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/7LxDpFLf2gfivUNP0c1TBg</id>
    <link href="https://mp.weixin.qq.com/s/7LxDpFLf2gfivUNP0c1TBg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>44个品种90个品规！第四集采名单流出！</title>
    <updated>2020-12-09T16:14:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/68sJapsoUWMAkG1nvBH-6g</id>
    <link href="https://mp.weixin.qq.com/s/68sJapsoUWMAkG1nvBH-6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从濒临破产到市值500亿，他如何打造血液灌流器帝国？</title>
    <updated>2020-12-09T16:14:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/oBP7FlDvHtw029JBbf0H4A</id>
    <link href="https://mp.weixin.qq.com/s/oBP7FlDvHtw029JBbf0H4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>超30亿PPI抑制剂「艾司奥美拉唑钠」，再添搅局者！</title>
    <updated>2020-12-09T16:14:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/LfchjNxoj0Vh9sVDVOxFTw</id>
    <link href="https://mp.weixin.qq.com/s/LfchjNxoj0Vh9sVDVOxFTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>独家专访！加快医药“产学研”一体化模式建设，其关键3点因素</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/yR8-pGxyekE348IndJ7Asw</id>
    <link href="https://mp.weixin.qq.com/s/yR8-pGxyekE348IndJ7Asw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH 2020| BCMA靶点开发：CAR-T、双抗、抗体偶联药物谁将率先胜出？</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/vzU90IsRfj0MrL_QNzA2tQ</id>
    <link href="https://mp.weixin.qq.com/s/vzU90IsRfj0MrL_QNzA2tQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采3进2，代理商的好机会？</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/MGAtlxh7kHTokWcFEzrW3g</id>
    <link href="https://mp.weixin.qq.com/s/MGAtlxh7kHTokWcFEzrW3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药监局出台GVP明确了药物警戒主体责任的承担者，将冲击所有MAH</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/Z7KZxSBGYvhrly3KXh5UEw</id>
    <link href="https://mp.weixin.qq.com/s/Z7KZxSBGYvhrly3KXh5UEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【更新版】药品技术转移、工艺验证和清洁验证最新要求与合规操作</title>
    <updated>2020-12-08T16:57:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/f2nu9kAjXm9bwu1nQjPtDQ</id>
    <link href="https://mp.weixin.qq.com/s/f2nu9kAjXm9bwu1nQjPtDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>